Literature DB >> 22547608

Pulmonary sarcoid-like granulomatosis induced by ipilimumab.

Grégoire Berthod1, Romain Lazor, Igor Letovanec, Emanuela Romano, Leslie Noirez, Jessica Mazza Stalder, Daniel E Speiser, Solange Peters, Olivier Michielin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22547608     DOI： 10.1200/JCO.2011.39.3298

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  47 in total

1.  Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.

Authors:  Sawsan Rashdan; John D Minna; David E Gerber
Journal:  Lancet Respir Med       Date:  2018-06       Impact factor: 30.700

2.  Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Authors:  Mizuki Nishino; Lynette M Sholl; Mark M Awad; Hiroto Hatabu; Philippe Armand; F Stephen Hodi
Journal:  Cancer Immunol Res       Date:  2018-04-05       Impact factor: 11.151

Review 3.  Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment.

Authors:  Mizuki Nishino; Sree H Tirumani; Nikhil H Ramaiya; F Stephen Hodi
Journal:  Eur J Radiol       Date:  2015-03-23       Impact factor: 3.528

Review 4.  Biological agents in gastrointestinal cancers: adverse effects and their management.

Authors:  Nivedita Arora; Arjun Gupta; Preet Paul Singh
Journal:  J Gastrointest Oncol       Date:  2017-06

5.  Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.

Authors:  Vanessa A Reed; Naiyer Rizvi
Journal:  Oncologist       Date:  2019-03-21

Review 6.  [The pathology of adverse events with immune checkpoint inhibitors].

Authors:  V H Koelzer; K Glatz; L Bubendorf; A Weber; A Gaspert; G Cathomas; A Lugli; A Zippelius; W Kempf; K D Mertz
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

7.  Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports.

Authors:  Joke Marlier; Veronique Cocquyt; Lieve Brochez; Simon Van Belle; Vibeke Kruse
Journal:  Endocrine       Date:  2014-02-21       Impact factor: 3.633

Review 8.  Toxicities of Immunotherapy for the Practitioner.

Authors:  Jeffrey S Weber; James C Yang; Michael B Atkins; Mary L Disis
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

9.  Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.

Authors:  Stephen W Reese; Eugene Cone; Maya Marchese; Brenda Garcia; Wesley Chou; Asha Ayub; Kerry Kilbridge; Gerald Weinhouse; Quoc-Dien Trinh
Journal:  Lung       Date:  2021-02-22       Impact factor: 2.584

Review 10.  Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Authors:  Mizuki Nishino; Hiroto Hatabu; F Stephen Hodi
Journal:  Radiology       Date:  2018-11-20       Impact factor: 11.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.